Sangre
The most recent articles from: June 1994
-
Clinical Trial
[Treatment of chronic myeloid leukemia using alpha-interferon and hydroxyurea. Study of 30 cases].
To evaluate the efficacy of the combination, alpha-interferon (IFN)-hydroxyurea (HU) in the treatment of patients with Philadelphia positive chronic myelogenous leukaemia (Ph'-CML). ⋯ The association of IFN and HU is effective and well tolerated in patients with low-risk CML, and it improves survival in CHR and overall survival.